155 related articles for article (PubMed ID: 18712715)
1. A graphical device to represent the outcomes of a logistic regression analysis.
Kranse R; Roobol M; Schröder FH
Prostate; 2008 Nov; 68(15):1674-80. PubMed ID: 18712715
[TBL] [Abstract][Full Text] [Related]
2. Development, validation, and head-to-head comparison of logistic regression-based nomograms and artificial neural network models predicting prostate cancer on initial extended biopsy.
Kawakami S; Numao N; Okubo Y; Koga F; Yamamoto S; Saito K; Fujii Y; Yonese J; Masuda H; Kihara K; Fukui I
Eur Urol; 2008 Sep; 54(3):601-11. PubMed ID: 18207312
[TBL] [Abstract][Full Text] [Related]
3. Evaluating localized prostate cancer and identifying candidates for focal therapy.
Sartor AO; Hricak H; Wheeler TM; Coleman J; Penson DF; Carroll PR; Rubin MA; Scardino PT
Urology; 2008 Dec; 72(6 Suppl):S12-24. PubMed ID: 19095124
[TBL] [Abstract][Full Text] [Related]
4. Validation of pretreatment nomograms for predicting indolent prostate cancer: efficacy in contemporary urological practice.
Dong F; Kattan MW; Steyerberg EW; Jones JS; Stephenson AJ; Schröder FH; Klein EA
J Urol; 2008 Jul; 180(1):150-4; discussion 154. PubMed ID: 18485398
[TBL] [Abstract][Full Text] [Related]
5. A critical appraisal of logistic regression-based nomograms, artificial neural networks, classification and regression-tree models, look-up tables and risk-group stratification models for prostate cancer.
Chun FK; Karakiewicz PI; Briganti A; Walz J; Kattan MW; Huland H; Graefen M
BJU Int; 2007 Apr; 99(4):794-800. PubMed ID: 17378842
[TBL] [Abstract][Full Text] [Related]
6. Initial biopsy outcome prediction--head-to-head comparison of a logistic regression-based nomogram versus artificial neural network.
Chun FK; Graefen M; Briganti A; Gallina A; Hopp J; Kattan MW; Huland H; Karakiewicz PI
Eur Urol; 2007 May; 51(5):1236-40; discussion 1241-3. PubMed ID: 16945477
[TBL] [Abstract][Full Text] [Related]
7. [Nomogram as predictive model in clinical practice].
Ohori Tatsuo Gondo And Riu Hamada M; Gondo T; Hamada R
Gan To Kagaku Ryoho; 2009 Jun; 36(6):901-6. PubMed ID: 19542708
[TBL] [Abstract][Full Text] [Related]
8. Development of a nomogram for predicting high-grade prostate cancer on biopsy: the significance of serum testosterone levels.
Ide H; Yasuda M; Nishio K; Saito K; Isotani S; Kamiyama Y; Muto S; Horie S
Anticancer Res; 2008; 28(4C):2487-92. PubMed ID: 18751439
[TBL] [Abstract][Full Text] [Related]
9. History of malignancy is a predictor of prostate cancer detection: incorporation into a pre-biopsy nomogram.
Kawakami S; Koga F; Fujii Y; Saito K; Yamamoto S; Tatokoro M; Yonese J; Kageyama Y; Fukui I; Kihara K
Int J Urol; 2008 Dec; 15(12):1055-60. PubMed ID: 19054174
[TBL] [Abstract][Full Text] [Related]
10. Nomogram use for the prediction of indolent prostate cancer: impact on screen-detected populations.
Roemeling S; Roobol MJ; Kattan MW; van der Kwast TH; Steyerberg EW; Schröder FH
Cancer; 2007 Nov; 110(10):2218-21. PubMed ID: 17893906
[TBL] [Abstract][Full Text] [Related]
11. Predictive models in diagnosing indolent cancer.
Bangma CH; Roobol MJ; Steyerberg EW
Cancer; 2009 Jul; 115(13 Suppl):3100-6. PubMed ID: 19544551
[TBL] [Abstract][Full Text] [Related]
12. Imaging low-risk prostate cancer.
Shukla-Dave A; Hricak H; Scardino PT
Curr Opin Urol; 2008 Jan; 18(1):78-86. PubMed ID: 18090495
[TBL] [Abstract][Full Text] [Related]
13. Cross-cultural validation of a prognostic tool: example of the Kattan preoperative nomogram as a predictor of prostate cancer recurrence after radical prostatectomy.
Rouprêt M; Hupertan V; Comperat E; Drouin SJ; Phé V; Xylinas E; Demanse D; Sibony M; Richard F; Cussenot O
BJU Int; 2009 Sep; 104(6):813-7; discussion 817-8. PubMed ID: 19254280
[TBL] [Abstract][Full Text] [Related]
14. Comparison of nomograms with other methods for predicting outcomes in prostate cancer: a critical analysis of the literature.
Shariat SF; Karakiewicz PI; Suardi N; Kattan MW
Clin Cancer Res; 2008 Jul; 14(14):4400-7. PubMed ID: 18628454
[TBL] [Abstract][Full Text] [Related]
15. The current state of brachytherapy nomograms for patients with clinically localized prostate cancer.
Nguyen CT; Zelefsky MJ; Kattan MW
Cancer; 2009 Jul; 115(13 Suppl):3121-7. PubMed ID: 19544540
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer.
Davison BJ; Oliffe JL; Pickles T; Mroz L
Oncol Nurs Forum; 2009 Jan; 36(1):89-96. PubMed ID: 19136342
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer nomograms: an update.
Chun FK; Karakiewicz PI; Briganti A; Gallina A; Kattan MW; Montorsi F; Huland H; Graefen M
Eur Urol; 2006 Nov; 50(5):914-26; discussion 926. PubMed ID: 16935414
[TBL] [Abstract][Full Text] [Related]
18. External validation and head-to-head comparison of Japanese and Western prostate biopsy nomograms using Japanese data sets.
Utsumi T; Kawamura K; Suzuki H; Kamiya N; Imamoto T; Miura J; Ueda T; Maruoka M; Sekita N; Mikami K; Ichikawa T
Int J Urol; 2009 Apr; 16(4):416-9. PubMed ID: 19226358
[TBL] [Abstract][Full Text] [Related]
19. How often do available preoperative risk factors accurately predict the risk assessed after surgery for localized prostate cancer?
Laudano MA; Lambert SM; Masson P; McCann TR; Desai M; Benson MC; McKiernan JM
BJU Int; 2009 Feb; 103(3):317-20. PubMed ID: 18778341
[TBL] [Abstract][Full Text] [Related]
20. Editorial comment on: development, validation, and head-to-head comparison of logistic regression-based nomograms and artificial neural network models predicting prostate cancer on initial extended biopsy.
Kattan MW
Eur Urol; 2008 Sep; 54(3):611. PubMed ID: 18207318
[No Abstract] [Full Text] [Related]
[Next] [New Search]
